Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Icagen. Inc. (ICGN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: ICGN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Biotech Tribulations Roundup: Failed Trials, Missed Targets, Business Mishaps
The Burrill Report
•
Nov 01
•
1 Comment
11 Ache-Free Investment Opportunities in Neuropathic Pain
Michael Becker
•
Sep 30
•
1 Comment
Potential Profit from Fall Allergy Season
Douglas Cress
•
Sep 02
•
Comment!
FDA Calendar Updates: Transcept Pharma Surges on Deal
Mike Havrilla
•
Aug 03
•
1 Comment
Looking for Laggards After the Latest Market Rally
Mike Havrilla
•
Dec 09
•
3 Comments
Biotech Day In Review: Roche Buys BioVeris For $600 Million
Centient Biotech Investor
•
Apr 05
•
1 Comment
More articles on ICGN »
Instablogs
Ache-free Investment Opportunities in Neuropathic Pain
Tue September 29, 2009
•
Michael Becker
•
Comment!
Write a post on ICGN
|
More Instablogs on ICGN »
Sentiment
What advice would you give to
ICGN?
123 characters left
What's your view of ICGN?
Make sure you include ICGN
140 characters left
|
Settings